PREVENTIVE OR THERAPEUTIC MEDICINES FOR DIABETES CONTAINING FUSED-HETEROCYCLE COMPOUNDS OR THEIR SALTS

Preventive or therapeutic medicines for diabetes, containing fused-heterocycle compounds of the general formula (I') or salts thereof as the active ingredient: (I') wherein G is CN, NO2, CO2R , CHO, SO2NRR, or CONRR; R is halogeno, -O-R , or S-R ; R is halogeno, -O-R (wherein R is as defin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: OMATSU, MASATO, MIYAMOTO, RYUJI, KATO, FUMINORI, KIMURA, HIROHIKO, YAMAMOTO, KAZUHIRO
Format: Patent
Sprache:eng ; fre ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator OMATSU, MASATO
MIYAMOTO, RYUJI
KATO, FUMINORI
KIMURA, HIROHIKO
YAMAMOTO, KAZUHIRO
description Preventive or therapeutic medicines for diabetes, containing fused-heterocycle compounds of the general formula (I') or salts thereof as the active ingredient: (I') wherein G is CN, NO2, CO2R , CHO, SO2NRR, or CONRR; R is halogeno, -O-R , or S-R ; R is halogeno, -O-R (wherein R is as defined above), or optionally substituted amino; and R and R are each independently hydrogen, halogeno, or alkyl. Cette invention se rapporte à des médicaments préventifs ou thérapeutiques contre le diabète, qui contiennent des composés à hétérocycle fusionné représentés par la formule générale (I') ou des sels de ces composés, comme principe actif. Dans ladite formule, G représente CN, NO2, CO2R , CHO, SO2NRR ou CONR; R représente halogénure, -O-R ou -S-R ; R représente halogéno, -O-R (où R est défini ci-dessus) ou un amino éventuellement substitué; et R et R représentent chacun séparément hydrogène, halogéno ou alkyle.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO0240485A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO0240485A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO0240485A13</originalsourceid><addsrcrecordid>eNqNjEEKwjAQRbtxIeod5gKFqhXcxmRqBtokJNMWV6VIuhIt1PtjFj2Aq8_77_O32eQ8dmiYOgTrgTV64bBlktCgIkkGA1TJKBI35ATSGhZkyNyhagOqXKfaW_mQNSbZONsaFdYz8hBEzWGfbabxtcTDmrsMKmSp8zh_hrjM4zO-43fobXEqi_J6EcfzH5MfimM1Jg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PREVENTIVE OR THERAPEUTIC MEDICINES FOR DIABETES CONTAINING FUSED-HETEROCYCLE COMPOUNDS OR THEIR SALTS</title><source>esp@cenet</source><creator>OMATSU, MASATO ; MIYAMOTO, RYUJI ; KATO, FUMINORI ; KIMURA, HIROHIKO ; YAMAMOTO, KAZUHIRO</creator><creatorcontrib>OMATSU, MASATO ; MIYAMOTO, RYUJI ; KATO, FUMINORI ; KIMURA, HIROHIKO ; YAMAMOTO, KAZUHIRO</creatorcontrib><description>Preventive or therapeutic medicines for diabetes, containing fused-heterocycle compounds of the general formula (I') or salts thereof as the active ingredient: (I') wherein G is CN, NO2, CO2R , CHO, SO2NRR, or CONRR; R is halogeno, -O-R , or S-R ; R is halogeno, -O-R (wherein R is as defined above), or optionally substituted amino; and R and R are each independently hydrogen, halogeno, or alkyl. Cette invention se rapporte à des médicaments préventifs ou thérapeutiques contre le diabète, qui contiennent des composés à hétérocycle fusionné représentés par la formule générale (I') ou des sels de ces composés, comme principe actif. Dans ladite formule, G représente CN, NO2, CO2R , CHO, SO2NRR ou CONR; R représente halogénure, -O-R ou -S-R ; R représente halogéno, -O-R (où R est défini ci-dessus) ou un amino éventuellement substitué; et R et R représentent chacun séparément hydrogène, halogéno ou alkyle.</description><edition>7</edition><language>eng ; fre ; jpn</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020523&amp;DB=EPODOC&amp;CC=WO&amp;NR=0240485A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020523&amp;DB=EPODOC&amp;CC=WO&amp;NR=0240485A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OMATSU, MASATO</creatorcontrib><creatorcontrib>MIYAMOTO, RYUJI</creatorcontrib><creatorcontrib>KATO, FUMINORI</creatorcontrib><creatorcontrib>KIMURA, HIROHIKO</creatorcontrib><creatorcontrib>YAMAMOTO, KAZUHIRO</creatorcontrib><title>PREVENTIVE OR THERAPEUTIC MEDICINES FOR DIABETES CONTAINING FUSED-HETEROCYCLE COMPOUNDS OR THEIR SALTS</title><description>Preventive or therapeutic medicines for diabetes, containing fused-heterocycle compounds of the general formula (I') or salts thereof as the active ingredient: (I') wherein G is CN, NO2, CO2R , CHO, SO2NRR, or CONRR; R is halogeno, -O-R , or S-R ; R is halogeno, -O-R (wherein R is as defined above), or optionally substituted amino; and R and R are each independently hydrogen, halogeno, or alkyl. Cette invention se rapporte à des médicaments préventifs ou thérapeutiques contre le diabète, qui contiennent des composés à hétérocycle fusionné représentés par la formule générale (I') ou des sels de ces composés, comme principe actif. Dans ladite formule, G représente CN, NO2, CO2R , CHO, SO2NRR ou CONR; R représente halogénure, -O-R ou -S-R ; R représente halogéno, -O-R (où R est défini ci-dessus) ou un amino éventuellement substitué; et R et R représentent chacun séparément hydrogène, halogéno ou alkyle.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwjAQRbtxIeod5gKFqhXcxmRqBtokJNMWV6VIuhIt1PtjFj2Aq8_77_O32eQ8dmiYOgTrgTV64bBlktCgIkkGA1TJKBI35ATSGhZkyNyhagOqXKfaW_mQNSbZONsaFdYz8hBEzWGfbabxtcTDmrsMKmSp8zh_hrjM4zO-43fobXEqi_J6EcfzH5MfimM1Jg</recordid><startdate>20020523</startdate><enddate>20020523</enddate><creator>OMATSU, MASATO</creator><creator>MIYAMOTO, RYUJI</creator><creator>KATO, FUMINORI</creator><creator>KIMURA, HIROHIKO</creator><creator>YAMAMOTO, KAZUHIRO</creator><scope>EVB</scope></search><sort><creationdate>20020523</creationdate><title>PREVENTIVE OR THERAPEUTIC MEDICINES FOR DIABETES CONTAINING FUSED-HETEROCYCLE COMPOUNDS OR THEIR SALTS</title><author>OMATSU, MASATO ; MIYAMOTO, RYUJI ; KATO, FUMINORI ; KIMURA, HIROHIKO ; YAMAMOTO, KAZUHIRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO0240485A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; jpn</language><creationdate>2002</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>OMATSU, MASATO</creatorcontrib><creatorcontrib>MIYAMOTO, RYUJI</creatorcontrib><creatorcontrib>KATO, FUMINORI</creatorcontrib><creatorcontrib>KIMURA, HIROHIKO</creatorcontrib><creatorcontrib>YAMAMOTO, KAZUHIRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OMATSU, MASATO</au><au>MIYAMOTO, RYUJI</au><au>KATO, FUMINORI</au><au>KIMURA, HIROHIKO</au><au>YAMAMOTO, KAZUHIRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PREVENTIVE OR THERAPEUTIC MEDICINES FOR DIABETES CONTAINING FUSED-HETEROCYCLE COMPOUNDS OR THEIR SALTS</title><date>2002-05-23</date><risdate>2002</risdate><abstract>Preventive or therapeutic medicines for diabetes, containing fused-heterocycle compounds of the general formula (I') or salts thereof as the active ingredient: (I') wherein G is CN, NO2, CO2R , CHO, SO2NRR, or CONRR; R is halogeno, -O-R , or S-R ; R is halogeno, -O-R (wherein R is as defined above), or optionally substituted amino; and R and R are each independently hydrogen, halogeno, or alkyl. Cette invention se rapporte à des médicaments préventifs ou thérapeutiques contre le diabète, qui contiennent des composés à hétérocycle fusionné représentés par la formule générale (I') ou des sels de ces composés, comme principe actif. Dans ladite formule, G représente CN, NO2, CO2R , CHO, SO2NRR ou CONR; R représente halogénure, -O-R ou -S-R ; R représente halogéno, -O-R (où R est défini ci-dessus) ou un amino éventuellement substitué; et R et R représentent chacun séparément hydrogène, halogéno ou alkyle.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; jpn
recordid cdi_epo_espacenet_WO0240485A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PREVENTIVE OR THERAPEUTIC MEDICINES FOR DIABETES CONTAINING FUSED-HETEROCYCLE COMPOUNDS OR THEIR SALTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T20%3A15%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OMATSU,%20MASATO&rft.date=2002-05-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO0240485A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true